Research.Patient.info
Higher Risk Myelodysplastic Syndromes research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE2
Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
This study tests a new drug called bexmarilimab alongside a standard treatment (azacitidine) for adults newly diagnosed with higher-risk myelodysplastic syndromes (MDS). Researchers want to find the safest and most effective dose, and see if combining these treatments helps manage this blood condition better than standard treatment alone.
United States · Czechia · Finland - recruitingPHASE1, PHASE2
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
This study is looking into a new drug, AZD3632, for certain blood cancers like leukaemia and myelodysplastic syndromes. It aims to check its safety, how well it works, and how the body handles it, both on its own and with another medicine.
United States · Australia · Canada